SYDNEY JACOBY: Open Payments
NPI 1114648649 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 19 payments from 9 companies in 2025. Trend: 2023 $619 · 2024 $231 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $143 |
| GENZYME CORPORATION | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| Amgen Inc. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| REVANCE THERAPEUTICS, INC. | 1 | $19 |
| Organon LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Botanix SB Inc | 1 | $14 |
Products named: RINVOQ, DUPIXENT, Zoryve, BOTOX, Otezla, CIBINQO, DAXXIFY, VTAMA.
Industry payments across NY — which companies pay providers there.
